Recognising Dr Daniel Kruschinski ~ Twenty simple signs to spot a psychopath.

Scientist: Twenty simple signs to spot a psychopath...

" The list includes: glibness and superficial charm, grandiose sense of self-worth, cunning/manipulative, pathological lying, emotional shallowness, callousness and lack of empathy, a tendency to boredom, impulsivity, criminal versatility, behavioural problems in early life, juvenile delinquency, and promiscuous sexual behaviour."
Click link above for more insight.

Huge Ethics Breech Dr Daniel Kruschinski of Germany Marries Surgical Patient after 20 Surgeries in One Month

This is about the most egregious breech of ethics a doctor can commit.
He brags of it on his website and sees nothing wrong with this. He claims in public her poor frantic family is jealous of him!  
She is at least 20 tears his junior. Repulsive!
Take a look.

ADHESIOLYSIS #2

Some of the cases with “Frozen abdomen” are so severe that they present not only adhesions to the abdominal wall and between the bowel loops, but have all organs and bowel loops surrounded by a very dense connective tissue, glueing the organs together and causing constrictions of the bowel.

Those patients need a “Multi-Step-Adhesiolysis” according to the EndoGyn concept and are informed after the first procedure that we will work upon their symptoms in different abdominal quadrants by setting-up a multistep adhesiolysis according to their symptoms.

The first step always includes full adhesiolysis of the abdominal wall as these adhesions are often causing bowel obstructions. Also a partial interluminal adhesiolysis of the bowel loop adhesions is included in the first step.

So in January 2010 the patient was admitted again and we performed the 3rd look procedure on January 18th, 2010, followed by 7 other laparoscopic procedures due to an infection and to avoid reformation of adhesions.

We had to keep the patient for 31 days in the hospital and she had all together 8 surgeries performed.

- 18/01/2010: Gasless Lift-Laparoscopy as 3rd look

– 20/01/2010: 4th look
- 25/01/2010: 5th look
- 27/01/2010: 6th look
- 29/01/2010: 7th look
- 01/02/2010: 8th look
- 05/02/2010: 9th look
- 09/01/2010: 10th look

Please check the text under the images!

PLEASE SCROLL DOWN!

http://laparoscopyofadhesiolysis.com/adhesiolysis-worst-cases-case-1-adhesiolysis-1

If you have a strong stomach, see her surgical photos where it appears he is combining 2 different adhesion barriers or using adept only even though everyone thinks they are getting sprayygel.

This poor woman is lucky to be alive. (IHRT opines her suffering has just begun.)

Here is some insight as to a proper patient and doctor relationship.

Opinion 8.14 - Sexual Misconduct in the Practice of Medicine

Sexual contact that occurs concurrent with the patient-physician relationship constitutes sexual misconduct. Sexual or romantic interactions between physicians and patients detract from the goals of the physician-patient relationship, may exploit the vulnerability of the patient, may obscure the physician’s objective judgment concerning the patient’s health care, and ultimately may be detrimental to the patient’s well-being.

If a physician has reason to believe that non-sexual contact with a patient may be perceived as or may lead to sexual contact, then he or she should avoid the non-sexual contact. At a minimum, a physician’s ethical duties include terminating the physician-patient relationship before initiating a dating, romantic, or sexual relationship with a patient.

Sexual or romantic relationships between a physician and a former patient may be unduly influenced by the previous physician-patient relationship. Sexual or romantic relationships with former patients are unethical if the physician uses or exploits trust, knowledge, emotions, or influence derived from the previous professional relationship. (I, II, IV)

Issued December 1989; Updated March 1992 based on the report "Sexual Misconduct in the Practice of Medicine," adopted December 1990 (JAMA. 1991;266:2741-2745).

Maryland follows New Jersey in Seprafilm Suit

AG Gansler: Genzyme Corp. Pays $22.28 Million for Fraudulent Marketing of ' Slurry' Improperly Used in Surgery Maryland Medicaid to receive $85,000 from Seprafilm allegations

AG Gansler: Genzyme Corp. Pays 22.28 Million for Fraudulent Marketing of ' Slurry' Improperly Used in Surgery Maryland Medicaid to receive 85,000 from Seprafilm allegations

Mar 10, 2014 (Menafn - M2 PRESSWIRE via COMTEX) --Attorney General Douglas F. Gansler announced today that Maryland, joined by other states and the federal government, has secured a settlement resolving allegations that Genzyme Corporation triggered false claims to be submitted to federal and state health care programs for unapproved use of a "slurry" version of its Seprafilm adhesion barrier. Genzyme will pay 22.28 million under the settlement. Maryland Medicaid will receive 84,627.69, to be shared with the federal government, which provides funding for the program.

"Cutting corners shows little concern for the wellbeing of the people who used this product and for the general public whose tax dollars support the Medicaid program," said Attorney General Gansler. "The profit from the fraudulent sales of this product will be forfeited and returned to its intended use."

Seprafilm is intended to reduce post-surgical adhesions by forming a bio-resorbable (broken down and assimilated back into the body) barrier between abdominal tissue and organs. This Food and Drug Administration (FDA)-approved product is for use in open abdominal surgery, but not for minimally invasive procedures such as laparoscopic surgery.

The settlement resolves allegations that Genzyme sales representatives taught doctors and other staff to cut the Seprafilm sheets into small pieces, add saline and allow the pieces to dissolve until the desired consistency was reached. This mixture was referred to as "slurry." Genzyme sales representatives traded recipes for slurry and trained each other how to produce it. The slurry was used in laparoscopic surgeries by inserting a catheter filled with the mixture into the body and applying it into the abdominal cavity. As a result of this conduct, Genzyme knowingly caused hospitals and other purchasers of Seprafilm to submit false and fraudulent claims to federal health care programs for uses that were not FDA-approved and therefore, not reimbursable.

Genzyme is a biotechnology corporation based in Cambridge, Mass., and was acquired by Sanofi-Aventis SA in April 2011.

Attorney General Gansler thanked Medicaid Fraud Control Unit Deputy Director Shelly Marie Martin for her work on this case. A National Association of Medicaid Fraud Control Units (NAMFCU) team participated in the investigation and conducted settlement negotiations with Genzyme.

Attorney General of Maryland 1 (888) 743-0023 toll-free / TDD: (410) 576-6372

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to info@m2.com.

(C)1994-2014 M2 COMMUNICATIONS